Search Results 111-120 of 16484 for Gemfibrozil

  1. AMZ002 Compared To Vigabatrin - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of AMZ002, compared to vigabatrin, in the treatment of infantle spasms (IS). Participation ...

  2. Irinotecan (intravenous route) - Side effects & uses - Mayo Clinic

    Gemfibrozil; Idelalisib; Indinavir; Influenza Virus Vaccine, Live; Ivacaftor; Ivosidenib; Leflunomide; Leniolisib; Letermovir; Lonafarnib; Lumacaftor ...

  3. Study Of Oraxol And Pembrolizumab In Subjects With Advanced Solid Tumors - Mayo Clinic

    Medication known to be strong inhibitors (gemfibrozil) or inducers (rifampin) of cytochrome P450;; (CYP)2C8. Subjects who are currently taking such ...

  4. An Extension Study Of Oral Ozanimod For Moderately-to-Severely Active Crohn's Disease - Mayo Clinic

    CYP2C8 inhibitors (eg, gemfibrozil or clopidogrel) and inducers (eg, rifampicin);; Monoamine oxidase inhibitors (eg, selegiline, phenelzine). Exclusions ...

  5. Retifanlimab And Epacadostat In Combination With Radiation And Bevacizumab In Patients With Recurrent Gliomas - Mayo Clinic

    ... gemfibrozil, glycyrrhetinic acid, glycyrrhizin, imatinib, imipramine, ketoconazole, linoleic acid supplements, mefenamic acid, mycophenolic acid, niflumic ...

  6. https://www.mayoclinic.org/patient_consumer_drug.xml

  7. A Study Of The Use Of A New Drug In People With Non-Alcoholic Steatohepatitis (NASH) Or Non-Alcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

    Additionally, if subjects are taking drugs such Vit E, Ursodeoxycholic acid, Gemfibrozil, anti TNF therapies and probiotics will be allowed if on stable doses ...

  8. A Study To Evaluate The Effectiveness, Safety, Pharmacokinetics And Pharmacodynamics Of Idasanutlin Monotherapy In Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera - Mayo Clinic

    Participation eligibility · CYP2C8 inhibitors such as gemfibrozil (also a UGT1A3 inhibitor); · CYP2C8 substrates such as repaglinide; · OATP1B1/3 substrates such ...

  9. Emricasan, A Caspase Inhibitor, For Evaluation In Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis - Mayo Clinic

    Gemfibrozil; Indinavir; Lopinavir; Ritonavir; Rifampin; Saquinavir; Simeprevir; Telaprevir; Tipranovir; Some combination of these medications. Symptoms of ...

  10. centers-of-excellence

    Overview Tab Title Description Study type Interventional Study IDs Study type Interventional Describes the nature of a clinical study.